These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 13650489)
1. Early activity in sporozoite-induced Plasmodium falciparum infections. JEFFERY GM; YOUNG MD; BURGESS RW; EYLES DE Ann Trop Med Parasitol; 1959 Apr; 53(1):51-8. PubMed ID: 13650489 [No Abstract] [Full Text] [Related]
2. Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria. Mo AX; Pesce J; Hall BF Vaccine; 2015 Jun; 33(25):2851-7. PubMed ID: 25917675 [TBL] [Abstract][Full Text] [Related]
3. The Complement System Contributes to Functional Antibody-Mediated Responses Induced by Immunization with Plasmodium falciparum Malaria Sporozoites. Behet MC; Kurtovic L; van Gemert GJ; Haukes CM; Siebelink-Stoter R; Graumans W; van de Vegte-Bolmer MG; Scholzen A; Langereis JD; Diavatopoulos DA; Beeson JG; Sauerwein RW Infect Immun; 2018 Jul; 86(7):. PubMed ID: 29735521 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Silvie O; Rubinstein E; Franetich JF; Prenant M; Belnoue E; Rénia L; Hannoun L; Eling W; Levy S; Boucheix C; Mazier D Nat Med; 2003 Jan; 9(1):93-6. PubMed ID: 12483205 [TBL] [Abstract][Full Text] [Related]
5. AMA1 and MAEBL are important for Plasmodium falciparum sporozoite infection of the liver. Yang ASP; Lopaticki S; O'Neill MT; Erickson SM; Douglas DN; Kneteman NM; Boddey JA Cell Microbiol; 2017 Sep; 19(9):. PubMed ID: 28371168 [TBL] [Abstract][Full Text] [Related]
6. Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children. Kurtovic L; Behet MC; Feng G; Reiling L; Chelimo K; Dent AE; Mueller I; Kazura JW; Sauerwein RW; Fowkes FJI; Beeson JG BMC Med; 2018 Apr; 16(1):61. PubMed ID: 29706136 [TBL] [Abstract][Full Text] [Related]
7. Sporozoite transmission by Anopheles freeborni and Anopheles gambiae experimentally infected with Plasmodium falciparum. Beier JC; Beier MS; Vaughan JA; Pumpuni CB; Davis JR; Noden BH J Am Mosq Control Assoc; 1992 Dec; 8(4):404-8. PubMed ID: 1474388 [TBL] [Abstract][Full Text] [Related]
8. Strong concordance between percent inhibition in oocyst and sporozoite intensities in a Plasmodium falciparum standard membrane-feeding assay. Miura K; Swihart BJ; Deng B; Zhou L; Pham TP; Diouf A; Fay MP; Long CA Parasit Vectors; 2019 May; 12(1):206. PubMed ID: 31060594 [TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity. Lasonder E; Janse CJ; van Gemert GJ; Mair GR; Vermunt AM; Douradinha BG; van Noort V; Huynen MA; Luty AJ; Kroeze H; Khan SM; Sauerwein RW; Waters AP; Mann M; Stunnenberg HG PLoS Pathog; 2008 Oct; 4(10):e1000195. PubMed ID: 18974882 [TBL] [Abstract][Full Text] [Related]
10. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge. Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584 [TBL] [Abstract][Full Text] [Related]
11. Ingestion of Plasmodium falciparum sporozoites during transmission by anopheline mosquitoes. Beier MS; Davis JR; Pumpuni CB; Noden BH; Beier JC Am J Trop Med Hyg; 1992 Aug; 47(2):195-200. PubMed ID: 1503188 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Panamanian Aotus lemurinus lemurinus to sporozoite-induced Plasmodium falciparum (Santa Lucia) infection. Gramzinski RA; Obaldia N; Jones TR; Rossan RN; Collins WE; Garrett DO; Lal AA; Hoffman SL Am J Trop Med Hyg; 1999 Jul; 61(1):19-25. PubMed ID: 10432049 [TBL] [Abstract][Full Text] [Related]
13. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates. Annoura T; Ploemen IH; van Schaijk BC; Sajid M; Vos MW; van Gemert GJ; Chevalley-Maurel S; Franke-Fayard BM; Hermsen CC; Gego A; Franetich JF; Mazier D; Hoffman SL; Janse CJ; Sauerwein RW; Khan SM Vaccine; 2012 Mar; 30(16):2662-70. PubMed ID: 22342550 [TBL] [Abstract][Full Text] [Related]
14. Cell Traversal Activity Is Important for Plasmodium falciparum Liver Infection in Humanized Mice. Yang ASP; O'Neill MT; Jennison C; Lopaticki S; Allison CC; Armistead JS; Erickson SM; Rogers KL; Ellisdon AM; Whisstock JC; Tweedell RE; Dinglasan RR; Douglas DN; Kneteman NM; Boddey JA Cell Rep; 2017 Mar; 18(13):3105-3116. PubMed ID: 28355563 [TBL] [Abstract][Full Text] [Related]
15. Development of whole sporozoite malaria vaccines. Hollingdale MR; Sedegah M Expert Rev Vaccines; 2017 Jan; 16(1):45-54. PubMed ID: 27327875 [TBL] [Abstract][Full Text] [Related]
16. Aotus nancymaae as a potential model for the testing of anti-sporozoite and liver stage vaccines against Plasmodium falciparum. Collins WE; Sullivan JS; Williams A; Nace D; Williams T; Galland GG; Barnwell JW Am J Trop Med Hyg; 2006 Mar; 74(3):422-4. PubMed ID: 16525100 [TBL] [Abstract][Full Text] [Related]
17. Ex vivo lymphocyte phenotyping during Plasmodium falciparum sporozoite immunization in humans. Bijker EM; Schats R; Visser LG; Sauerwein RW; Scholzen A Parasite Immunol; 2015 Nov; 37(11):590-8. PubMed ID: 26363409 [TBL] [Abstract][Full Text] [Related]
18. A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites. van Schaijk BC; Ploemen IH; Annoura T; Vos MW; Foquet L; van Gemert GJ; Chevalley-Maurel S; van de Vegte-Bolmer M; Sajid M; Franetich JF; Lorthiois A; Leroux-Roels G; Meuleman P; Hermsen CC; Mazier D; Hoffman SL; Janse CJ; Khan SM; Sauerwein RW Elife; 2014 Nov; 3():. PubMed ID: 25407681 [TBL] [Abstract][Full Text] [Related]
19. The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines. Espinosa DA; Vega-Rodriguez J; Flores-Garcia Y; Noe AR; Muñoz C; Coleman R; Bruck T; Haney K; Stevens A; Retallack D; Allen J; Vedvick TS; Fox CB; Reed SG; Howard RF; Salman AM; Janse CJ; Khan SM; Zavala F; Gutierrez GM Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895131 [TBL] [Abstract][Full Text] [Related]